| 000 | 01319 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250517004005.0 | ||
| 264 | 0 | _c20160601 | |
| 008 | 201606s 0 0 eng d | ||
| 022 | _a1875-6212 | ||
| 024 | 7 |
_a10.2174/1570161112666141127162209 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTang, Jie | |
| 245 | 0 | 0 |
_aPlatelet Inhibition Agents: Current and Future P2Y12 Receptor Antagonists. _h[electronic resource] |
| 260 |
_bCurrent vascular pharmacology _c2015 |
||
| 300 |
_a566-77 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review | ||
| 650 | 0 | 4 |
_aAcute Coronary Syndrome _xphysiopathology |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aPercutaneous Coronary Intervention _xmethods |
| 650 | 0 | 4 |
_aPlatelet Aggregation _xdrug effects |
| 650 | 0 | 4 |
_aPlatelet Aggregation Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aPurinergic P2Y Receptor Antagonists _xpharmacology |
| 650 | 0 | 4 |
_aReceptors, Purinergic P2Y12 _xdrug effects |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 700 | 1 | _aLi, Mu-Peng | |
| 700 | 1 | _aZhou, Hong-Hao | |
| 700 | 1 | _aChen, Xiao-Ping | |
| 773 | 0 |
_tCurrent vascular pharmacology _gvol. 13 _gno. 5 _gp. 566-77 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2174/1570161112666141127162209 _zAvailable from publisher's website |
| 999 |
_c24395463 _d24395463 |
||